Villers-les-Nancy, 12 December 2012 - 18:00 (CET)
PRESS RELEASE
PHARMAGEST INTERACTIVE SA ADMITTED TO LONG-ONLY DEFERRED SETTLEMENT SERVICE (SRD)
PHARMAGEST INTERACTIVE is proud to announce today that its shares will be negotiable under the "long-only deferred settlement service (SRD) of the NYSE Euronext Paris(TM) with effect from 24th December this year.
Due to a sufficiently high volume of minimum daily transactions, the PHARMAGEST INTERACTIVE share will be admitted to the "long-only" deferred settlement service (SRD) with effect from the stock market session of 24 December 2012.
The deferred settlement service (SRD) is a simple mechanism that, whilst remaining within the stringent prudential rules, enables investors to purchase shares with a lever on values by means of a regulated market. The idea of "long-only" means that the value will only be eligible for purchase with lever.
Thierry CHAPUSOT Chairman of the Board of Directors comments:
"The association of the PHARMAGEST share with the deferred settlement service (SRD) label is excellent news for all our shareholders and today we are very proud to be able to bring them the benefits of this mechanism. The admission of PHARMAGEST INTERACTIVE to "long-only" deferred settlement service (SRD) status will provide the share with even greater visibility and improved liquidity".
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 700 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.
As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centres for the elderly), through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services® ), creator of value for the patient, pharmacist and laboratory, dynamizes sales, optimizes purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.
At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecureTM ).
Listed on the NYSE Euronext Paris(TM) - Compartment C
Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
Find out the latest news from the group at www.pharmagest.com
CONTACTS
Analyst and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO Isabelle APRILE
Tel. 01 39 97 61 22 - i.aprile@finextenso.fr
